Stay updated on Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial page.

Latest updates to the Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial page
- Check2 days agoChange DetectedA site-wide funding notice was added and the page version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check9 days agoChange DetectedUI enhancements to the Record History page include a glossary toggle, color-coded highlights for changes (green for additions, red for deletions), and a new revision label: Revision: v3.4.0. A capitalization change is shown for the No FEAR Act Data item.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check45 days agoChange DetectedA new revision entry (Revision: v3.3.3) was added to the Record History, and the HHS Vulnerability Disclosure entry as well as the earlier Revision: v3.3.2 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page shows Revision: v3.3.2 in the footer replacing the previous v3.3.1, with no other visible content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check73 days agoChange DetectedA new revision entry v3.3.1 was added to the history and the prior v3.2.0 entry was removed. This is an administrative update with no impact on the study information.SummaryDifference0.0%

Stay in the know with updates to Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial page.